Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation.

about

Anti-vascular endothelial growth factor treatment in diabetic macular edema.Punctate retinal hemorrhage and its relation to ocular and systemic disease in dogs: 83 cases.

P2860

Q37241685-9023905D-1A13-44B8-96E8-D9AAF09046F8 Q47299687-2F8E82C0-AC30-4780-90A7-559CDAF6B84B

P2860

Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation.

Item

http://www.wikidata.org/entity/Q35996718

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical effects and safety of ...... with retinal photocoagulation.

@ast

Clinical effects and safety of ...... with retinal photocoagulation.

@en

type

Item

label

Clinical effects and safety of ...... with retinal photocoagulation.

@ast

Clinical effects and safety of ...... with retinal photocoagulation.

@en

prefLabel

Clinical effects and safety of ...... with retinal photocoagulation.

@ast

Clinical effects and safety of ...... with retinal photocoagulation.

@en

P1476

Clinical effects and safety of ...... with retinal photocoagulation.

@en

P2093

Cheng Qian

http://www.w3.org/2001/XMLSchema#string

Guangming Wan

http://www.w3.org/2001/XMLSchema#string

Panshi Yan

http://www.w3.org/2001/XMLSchema#string

Wenzhan Wang

http://www.w3.org/2001/XMLSchema#string

Yi Dong

http://www.w3.org/2001/XMLSchema#string

Yue Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.

Focal laser photocoagulation in non-center involved diabetic macular edema.

Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography.

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathy

Correlation between spectral domain optical coherence tomography findings and visual outcomes in central retinal vein occlusion.

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

Critical appraisal of ranibizumab in the treatment of diabetic macular edema.

Global prevalence and major risk factors of diabetic retinopathy.

P304

527-533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S99224

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27103811

http://www.w3.org/2001/XMLSchema#string

P921

Light Coagulation

P932

4827417

http://www.w3.org/2001/XMLSchema#string

Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation.

about

P2860

P2860

Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932